CN103278469A - 一种总蛋白检测试剂 - Google Patents
一种总蛋白检测试剂 Download PDFInfo
- Publication number
- CN103278469A CN103278469A CN2013102005749A CN201310200574A CN103278469A CN 103278469 A CN103278469 A CN 103278469A CN 2013102005749 A CN2013102005749 A CN 2013102005749A CN 201310200574 A CN201310200574 A CN 201310200574A CN 103278469 A CN103278469 A CN 103278469A
- Authority
- CN
- China
- Prior art keywords
- reagent
- total protein
- protein according
- detects
- dilution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 59
- 238000002331 protein detection Methods 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 6
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 6
- 238000004108 freeze drying Methods 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 238000010790 dilution Methods 0.000 claims description 23
- 239000012895 dilution Substances 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 230000002421 anti-septic effect Effects 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical class COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- 229920000151 polyglycol Polymers 0.000 claims description 6
- 239000010695 polyglycol Substances 0.000 claims description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 claims description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 230000002452 interceptive effect Effects 0.000 claims description 5
- VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 claims description 5
- 229940074446 sodium potassium tartrate tetrahydrate Drugs 0.000 claims description 5
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- 150000005846 sugar alcohols Chemical class 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- 108010015428 Bilirubin oxidase Proteins 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- -1 potassium ferricyanide Chemical compound 0.000 claims description 3
- 239000000276 potassium ferrocyanide Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 claims description 2
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 125000000647 trehalose group Chemical group 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- 239000003085 diluting agent Substances 0.000 abstract 2
- 229910000365 copper sulfate Inorganic materials 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- FYFFGSSZFBZTAH-UHFFFAOYSA-N methylaminomethanetriol Chemical compound CNC(O)(O)O FYFFGSSZFBZTAH-UHFFFAOYSA-N 0.000 abstract 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 abstract 1
- 229940074439 potassium sodium tartrate Drugs 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 abstract 1
- 238000012123 point-of-care testing Methods 0.000 description 20
- 239000000523 sample Substances 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200574.9A CN103278469B (zh) | 2013-05-24 | 2013-05-24 | 一种总蛋白检测试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200574.9A CN103278469B (zh) | 2013-05-24 | 2013-05-24 | 一种总蛋白检测试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103278469A true CN103278469A (zh) | 2013-09-04 |
CN103278469B CN103278469B (zh) | 2015-08-12 |
Family
ID=49061052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310200574.9A Active CN103278469B (zh) | 2013-05-24 | 2013-05-24 | 一种总蛋白检测试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103278469B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106442352A (zh) * | 2016-09-24 | 2017-02-22 | 济南中安生物技术服务有限公司 | 一种抗干扰能力强的血清总蛋白检测试剂盒 |
CN106525829A (zh) * | 2016-10-31 | 2017-03-22 | 百奥森(江苏)食品安全科技有限公司 | 一种蛋白质快速检测试纸及其制备方法 |
CN107525774A (zh) * | 2016-06-21 | 2017-12-29 | 山东博科生物产业有限公司 | 氢氧化钾法总蛋白诊断检测试剂盒 |
CN110632325A (zh) * | 2019-09-27 | 2019-12-31 | 昆山迪安医学检验实验室有限公司 | 一种总蛋白检测试剂及其制备方法 |
CN111157712A (zh) * | 2018-11-07 | 2020-05-15 | 深圳迈瑞生物医疗电子股份有限公司 | 可抗脂血干扰的血液样本检测试剂盒及方法 |
CN113281520A (zh) * | 2021-04-26 | 2021-08-20 | 深圳市锦瑞生物科技有限公司 | 血清总蛋白测定试剂球的制备方法、试剂球及微流控芯片 |
CN114011480A (zh) * | 2021-11-04 | 2022-02-08 | 上海速创诊断产品有限公司 | 一种电化学发光微流控检测芯片及用于蛋白检测的试剂盒 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1019898A (ja) * | 1996-07-01 | 1998-01-23 | Internatl Reagents Corp | 総蛋白質の定量方法および定量用試薬 |
CN101034065A (zh) * | 2006-03-07 | 2007-09-12 | 桑华春 | 乳粉蛋白质含量快速检测试剂盒及其制备方法 |
CN101226198A (zh) * | 2007-01-16 | 2008-07-23 | 温州市第三人民医院 | 一种糖化血清蛋白的酶法测定方法及液体稳定试剂 |
CN101363869A (zh) * | 2007-08-07 | 2009-02-11 | 江西铜业集团公司 | 血清总蛋白双试剂双缩脲测定方法 |
CN102507916A (zh) * | 2011-11-07 | 2012-06-20 | 宁波美康生物科技股份有限公司 | 缺血修饰白蛋白液体稳定试剂盒 |
CN102650591A (zh) * | 2012-04-06 | 2012-08-29 | 上海蓝怡科技有限公司 | 测定糖化血清蛋白的试剂盒 |
-
2013
- 2013-05-24 CN CN201310200574.9A patent/CN103278469B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1019898A (ja) * | 1996-07-01 | 1998-01-23 | Internatl Reagents Corp | 総蛋白質の定量方法および定量用試薬 |
CN101034065A (zh) * | 2006-03-07 | 2007-09-12 | 桑华春 | 乳粉蛋白质含量快速检测试剂盒及其制备方法 |
CN101226198A (zh) * | 2007-01-16 | 2008-07-23 | 温州市第三人民医院 | 一种糖化血清蛋白的酶法测定方法及液体稳定试剂 |
CN101363869A (zh) * | 2007-08-07 | 2009-02-11 | 江西铜业集团公司 | 血清总蛋白双试剂双缩脲测定方法 |
CN102507916A (zh) * | 2011-11-07 | 2012-06-20 | 宁波美康生物科技股份有限公司 | 缺血修饰白蛋白液体稳定试剂盒 |
CN102650591A (zh) * | 2012-04-06 | 2012-08-29 | 上海蓝怡科技有限公司 | 测定糖化血清蛋白的试剂盒 |
Non-Patent Citations (2)
Title |
---|
丛辉等: ""高铁氰化钾法消除胆红素对测定总蛋白质结果影响的研究"", 《现代检验医学杂志》, vol. 19, no. 6, 30 November 2004 (2004-11-30), pages 20 - 21 * |
袁水斌等: ""稳定型总蛋白(TP)试剂的研制"", 《江西医学检验》, vol. 24, no. 2, 30 April 2006 (2006-04-30), pages 124 - 126 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107525774A (zh) * | 2016-06-21 | 2017-12-29 | 山东博科生物产业有限公司 | 氢氧化钾法总蛋白诊断检测试剂盒 |
CN106442352A (zh) * | 2016-09-24 | 2017-02-22 | 济南中安生物技术服务有限公司 | 一种抗干扰能力强的血清总蛋白检测试剂盒 |
CN106525829A (zh) * | 2016-10-31 | 2017-03-22 | 百奥森(江苏)食品安全科技有限公司 | 一种蛋白质快速检测试纸及其制备方法 |
CN111157712A (zh) * | 2018-11-07 | 2020-05-15 | 深圳迈瑞生物医疗电子股份有限公司 | 可抗脂血干扰的血液样本检测试剂盒及方法 |
CN110632325A (zh) * | 2019-09-27 | 2019-12-31 | 昆山迪安医学检验实验室有限公司 | 一种总蛋白检测试剂及其制备方法 |
CN113281520A (zh) * | 2021-04-26 | 2021-08-20 | 深圳市锦瑞生物科技有限公司 | 血清总蛋白测定试剂球的制备方法、试剂球及微流控芯片 |
CN114011480A (zh) * | 2021-11-04 | 2022-02-08 | 上海速创诊断产品有限公司 | 一种电化学发光微流控检测芯片及用于蛋白检测的试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN103278469B (zh) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103278648B (zh) | 一种白蛋白检测试剂 | |
CN103276052B (zh) | 一种尿素氮检测试剂 | |
CN103278469B (zh) | 一种总蛋白检测试剂 | |
CN103278468B (zh) | 一种肌酐检测试剂 | |
CN103266166B (zh) | 一种葡萄糖检测试剂 | |
CN103320498B (zh) | 一种天冬氨酸氨基转移酶检测试剂 | |
CN103278652B (zh) | 一种总胆红素检测试剂 | |
Schnabl et al. | Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing | |
CN103320497B (zh) | 一种丙氨酸氨基转移酶检测试剂 | |
Brunk et al. | Colorimetric method for free fatty acids in serum validated by comparison with gas chromatography. | |
Kocijancic et al. | Evaluation of the BD Vacutainer® RST blood collection tube for routine chemistry analytes: clinical significance of differences and stability study | |
CN104673879A (zh) | 一种小而密低密度脂蛋白胆固醇检测试剂盒及其制备 | |
CN103276051B (zh) | 一种碱性磷酸酶检测试剂 | |
CN102041296A (zh) | 一种血清低密度脂蛋白胆固醇(ldl-c)匀相法体外诊断试剂 | |
CN103266165B (zh) | 一种淀粉酶检测试剂 | |
CN103266164B (zh) | 一种亮氨酸氨基肽酶检测试剂 | |
CN103333945B (zh) | 一种直接胆红素检测试剂 | |
CN104673880A (zh) | 一种小而密低密度脂蛋白胆固醇检测试方法 | |
CN108949902A (zh) | 一种血清小而密低密度脂蛋白胆固醇检测试剂盒 | |
CN107153121A (zh) | 糖化血红蛋白、血红蛋白检测试剂盒及其检测方法 | |
CN104569430B (zh) | 一种快速定量检测心脏型脂肪酸结合蛋白的均相荧光免疫试剂组及其制备方法 | |
CN105606418A (zh) | 一种检测糖化血红蛋白的一体化试剂盒及其检测方法 | |
CN103290097B (zh) | 一种γ-谷氨酰基转移酶检测试剂 | |
Fraser et al. | Better laboratory evaluations of instruments and kits are required. | |
Yuwadee et al. | Simple spectrophotometric sequential injection analysis system for determination of serum calcium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zou Bingde Inventor after: Zou Jihua Inventor after: Zhang Guichun Inventor after: Wo Yanbo Inventor before: Zou Bingde Inventor before: Zou Jihua Inventor before: Zhang Guichun Inventor before: Wo Yanbo Inventor before: Zhou Haibin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZOU BINGDE ZOU JIHUA ZHANG GUICHUN WO YANBO ZHOU HAIBIN TO: ZOU BINGDE ZOU JIHUA ZHANG GUICHUN WO YANBO |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299 Patentee after: MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Address before: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299 Patentee before: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130904 Assignee: Ningbo Shengyuan Biotechnology Co., Ltd. Assignor: MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Contract record no.: X2022330000361 Denomination of invention: A total protein detection reagent Granted publication date: 20150812 License type: Common License Record date: 20220809 |
|
EE01 | Entry into force of recordation of patent licensing contract |